CA-JUNIPER-NETWORKS
11.3.2024 20:26:32 CET | Business Wire | Press release
Juniper Networks (NYSE: JNPR), a leader in secure AI-Native Networking, today announced that Gartner, Inc. has named it a Leader in the 2024 Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure for the fourth time in a row. In the latest iteration of this Magic Quadrant, for the third time straight, Juniper is also positioned furthest in “Completeness of Vision,” a Gartner rating criterion that reflects innovation, and evaluates vendors on their ability to communicate that they understand client business issues in their target markets and have the products, services, vision and strategies to address these issues. In addition, Juniper was once again positioned highest for “Ability to Execute,” a Gartner rating criterion that evaluates vendors on their product/service, market responsiveness and customer experience.
As Gartner explains, “Magic Quadrants offer visual snapshots, in-depth analyses and actionable advice that provide insight into a market’s direction, maturity and participants. Assessing the market and its technology and service providers is a business-critical task. Vendor differentiation based on variations in operations, customer satisfaction, level of complexity and strategy can make comparisons of vendor offerings challenging. In addition, the market’s overall direction is often evolving. Gartner’s Magic Quadrants solve these problems by offering snapshots of markets and their participants, and help you map vendor strengths and cautions against your current and future needs.”
“We believe this latest recognition as a Leader by Gartner reinforces the value our products deliver for our customers,” said Sudheer Matta, Group Vice President, Products for the AI-Native Enterprise, Juniper Networks. “By delivering full-stack automation, insight and self-driving actions, Mist AI continues to stand out from the rest of the industry for fast deployments, the fewest tickets and quickest problem resolution. The momentum we are seeing is a true testament to our vision to design the industry’s first AI-Native Networking Platform from the ground up to provide reliable and consistent Wi-Fi experiences. By using automation to reduce or eliminate time-consuming manual tasks, and implementing automated workflows to proactively fix issues before they impact users, we consistently deliver proven value, saving substantial time and money for our customers and partners worldwide.”
In addition, Juniper recently announced record 2023 revenue results, marking the third consecutive year of business growth on a year-over-year basis. Juniper’s AI-Native enterprise solutions significantly outpaced the market, with revenue from wired and wireless access products attached to the Mist cloud growing nearly 70% on a full-year basis.
And as reported by the 650 Group Wireless LAN Infrastructure Quarterly Market & Long-Term Forecast Report 4Q23, published on March 1, 2024, while most of the industry contracted in Q4, Juniper continued its strong growth both Q/Q and Y/Y. In addition, Juniper was the fastest growing vendor on a full calendar year basis from 2022 to 2023.
Juniper solutions are deployed and helping drive better connections in 4 of the Fortune 10, 3 of the top-3 retailers, 2 of the top-5 Fintech companies, top Global universities, and the #1 healthcare provider in the United States. And Juniper’s public customer wins continue to expand across all verticals, with a host of new public success stories, including:
James Cook University Singapore
Juniper’s recognition in the Magic Quadrant for latest Enterprise Wired and Wireless LAN Infrastructure report is in addition to Gartner also recently naming Juniper Networks a Leader in the 2024 Gartner Magic Quadrant for Indoor Location Services for the third year in a row.
As the only vendor named a Leader in both the Wired and Wireless LAN Infrastructure and Indoor Location Services Magic Quadrant reports, Juniper believes its solutions are uniquely positioned to deliver exceptional experiences for both operators and end users. Automation in Juniper’s wired and wireless solutions not only helps accelerate deployments and eliminate up to 90% of networking-related trouble tickets, but our indoor location services offer customers and partners a scalable and cost-effective way to personalize wireless experiences with value-added features like wayfinding, asset location, and contextual notifications.
Additional Resources
- 2024 Gartner Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure: View Report
- Blog: Juniper’s Fourth Time in a Row: A Leader in the 2024 Gartner® Magic Quadrant™ for Enterprise Wired and Wireless LAN Infrastructure
- 2024 Gartner Magic Quadrant for Indoor Location Services: View Report
- Blog: Three Years in a Row: Juniper Networks® Once Again Named a Leader in the 2024 Gartner® Magic Quadrant™ for Indoor Location Services
- Juniper industry recognition: Learn more
Gartner Disclaimer
Gartner, Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure, Tim Zimmerman, Christian Canales, Nauman Raja, Mike Leibovitz 6 March 2024.
Gartner Magic Quadrant for Indoor Location Services, Global, Tim Zimmerman, Annette Zimmermann, et al., 28 February 2024.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved. Juniper Networks is recognized as Juniper in the 2024, 2022, and 2021 Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure reports.
About Juniper Networks
Juniper Networks believes that connectivity is not the same as experiencing a great connection. Juniper's AI-Native Networking Platform is built from the ground up to leverage AI to deliver the best and most secure user experiences from the edge to the data center and cloud. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on X (Twitter) LinkedIn and Facebook.
Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240311703596/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom